Passage Bio, Inc. (PASG) Reports In-Line Q1 EPS
Passage Bio, Inc. (NASDAQ: PASG) reported Q1 EPS of ($0.25), in-line with the analyst estimate of ($0.25).
For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.
Passage Bio, Inc. (NASDAQ: PASG) reported Q1 EPS of ($0.25), in-line with the analyst estimate of ($0.25).
For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.